Kathryn J Ray

Summary

Publications

  1. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
  2. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
  3. doi request reprint Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
  4. doi request reprint Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
  5. pmc When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, California, United States of America
    PLoS Negl Trop Dis 3:e458. 2009
  6. doi request reprint Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial
    Travis C Porco
    F I Proctor Foundation, and Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA
    JAMA 302:962-8. 2009
  7. pmc Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
  8. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013
  9. doi request reprint Complete elimination is a difficult goal for trachoma programs in severely affected communities
    Deborah A Gill
    F I Proctor Foundation, San Francisco, USA
    Clin Infect Dis 46:564-6. 2008
  10. pmc Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I
    Catherine Q Sun
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 54:4167-73. 2013

Collaborators

Detail Information

Publications14

  1. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
    ..Here we use mathematical models to demonstrate that repeated antibiotic distributions can eliminate infection in a reasonable time period...
  2. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
    ....
  3. doi request reprint Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
    ..To analyze the relationship between fluoroquinolone use at presentation and minimum inhibitory concentration in bacterial keratitis...
  4. doi request reprint Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
    ..We assessed indirect protection against trachoma with mass azithromycin distributions...
  5. pmc When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, California, United States of America
    PLoS Negl Trop Dis 3:e458. 2009
    ..While this can be tested empirically, results will not be available for years. Here we use a mathematical model to predict results with different graduation strategies in three African countries...
  6. doi request reprint Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial
    Travis C Porco
    F I Proctor Foundation, and Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA
    JAMA 302:962-8. 2009
    ..Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria--frequent causes of childhood mortality in trachoma-endemic areas...
  7. pmc Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
    ..09-4.26, pā€‰=ā€‰0.027). Conclusions: We found a sharp increase in the proportion of isolates that were resistant to moxifloxacin from 2007 to 2009. Further work needs to be done to characterize the nature of this increase...
  8. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013
    ..In this report, we analyze the role of moxifloxacin susceptibility in the relationship between causative organisms and clinical outcome in bacteria keratitis...
  9. doi request reprint Complete elimination is a difficult goal for trachoma programs in severely affected communities
    Deborah A Gill
    F I Proctor Foundation, San Francisco, USA
    Clin Infect Dis 46:564-6. 2008
    ..Theoretically, a loftier goal of elimination is feasible. Here, we demonstrate that, although local elimination of infection in the most severely affected communities is difficult, it is possible with biannual antibiotic distributions...
  10. pmc Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I
    Catherine Q Sun
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 54:4167-73. 2013
    ..To perform a Bayesian analysis of the Mycotic Ulcer Treatment Trial I (MUTT I) using expert opinion as a prior belief...
  11. doi request reprint The epidemiological dynamics of infectious trachoma may facilitate elimination
    Thomas M Lietman
    F I Proctor Foundation, University of California, San Francisco, CA, 94143 0412, USA
    Epidemics 3:119-24. 2011
    ..Here, we use mathematical models to assess whether more ambitious goals such as local elimination or even global eradication are possible...
  12. pmc Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity
    Fengchen Liu
    F I Proctor Foundation, University of California, San Francisco, California, USA
    PLoS Negl Trop Dis 7:e2303. 2013
    ..This is encouraging, as it allows the possibility that repeated mass antibiotic distributions may eliminate infection from even the most severely affected areas. ..
  13. pmc Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study
    Durga S Borkar
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Ophthalmology 120:451-6. 2013
    ..To provide a population-based estimate of the incidence of herpes zoster ophthalmicus (HZO) with comparisons across racial, sex, and age groups, as well as to estimate the frequency of postherpetic neuralgia (PHN)...
  14. doi request reprint Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial
    Craig W See
    FI Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Ophthalmic Epidemiol 19:407-13. 2012
    ..To elicit expert opinion on the use of adjunctive corticosteroid therapy in bacterial corneal ulcers. To perform a Bayesian analysis of the Steroids for Corneal Ulcers Trial (SCUT), using expert opinion as a prior probability...